A Broadly Protecting Influenza Vaccine Relies on New Adjuvans Effects-Juniper Publishers
JUNIPER PUBLISHERS - OPEN ACCESS JOURNAL OF DAIRY & VETERINARY SCIENCES Short Communication Vaccines used against seasonal influenza are poorly effective against influenza A viruses of novel subtypes that may cause pandemic. Pre-pandemic influenza vaccines are poorly immunogenic against the upcoming pandemic virus that might be overcome by the use of a potent adjuvant. In humans, a limited number of adjuvants has been approved for human use and mostly human influenza vaccines are not adjuvanted.Furthermore, pre-pandemic influenza vaccines are poorly immunogenic to the upcoming pandemic. Thus, there is a need for alternative safe and effective adjuvants that can enhance the immunogenicity of influenza vaccines and that promote the induction of broad-protective T cell responses. Most studies of pandemic outbreaks have been done in humans. Also in animal spp problems exist with influenza virus infections. However, in the animal field the situation is different whe...